¼¼°èÀÇ ¸¸¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ Ä¡·áÁ¦ ½ÃÀå(2024-2028³â)
Global Chronic Lymphocytic Leukemia Therapeutics Market 2024-2028
»óǰÄÚµå : 1459541
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 155 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,617,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,787,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸¸¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ Ä¡·áÁ¦ ½ÃÀåÀº 2023-20281³â¿¡ 29¾ï 2,000¸¸ ´Þ·¯, ¿¹Ãø ±â°£ Áß CAGRÀº 8.82%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸¸¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ Ä¡·áÁ¦ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» Á¦°øÇÕ´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ´Ù¾çÇÑ Ç÷¾×¾Ï¿¡ ´ëÇÑ ¿¬±¸ º¸Á¶±ÝÀÇ Áõ°¡, ¸¸¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ÀÇ À¯º´·ü Áõ°¡, ³ë³â Àα¸ÀÇ Áõ°¡¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁسâ 2024
Á¾·á³â 2028
¿¹Ãø ±â°£ 2024-2028
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ 2024³â 7.54%
CAGR 8.82%
ÁõºÐ¾× 29¾ï 2,000¸¸ ´Þ·¯

º» Á¶»ç¿¡¼­´Â ¸¸¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ Ä¡·áÁ¦ÀÇ Æ¯È¿¾à ÁöÁ¤À» ÇâÈÄ ¼ö³â°£ ¸¸¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ Ä¡·áÁ¦ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ÀÌÀ¯ÀÇ Çϳª·Î ½Äº°Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Çõ½ÅÀûÀÎ ¸¸¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ Ä¡·áÁ¦¿¡ °üÇÑ ¿¬±¸°³¹ß Ȱµ¿ÀÇ Áõ°¡ ¹× ¸¸¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ Áø´ÜÀ» À§ÇÑ ¿¹Ãø ¹ÙÀÌ¿À¸¶Ä¿ÀÇ »ç¿ë Áõ°¡°¡ ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ±¸µµ

Á¦3Àå ½ÃÀå ±Ô¸ðÀÇ Æò°¡

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦5Àå Five forces ºÐ¼®

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : Åõ¿© °æ·Îº°

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­ : Å×¶óÇÇ

Á¦8Àå °í°´ »óȲ

Á¦9Àå Áö¿ªº° »óȲ

Á¦10Àå ÃËÁø¿äÀÎ, °úÁ¦ ¹× µ¿Çâ

Á¦11Àå º¥´õ ±¸µµ

Á¦12Àå º¥´õ ºÐ¼®

Á¦13Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The chronic lymphocytic leukemia therapeutics market is forecasted to grow by USD 2.92 bn during 2023-2028, accelerating at a CAGR of 8.82% during the forecast period. The report on the chronic lymphocytic leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing research grants for different blood cancers, the increasing prevalence of chronic lymphocytic leukemia, and the growing geriatric population.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.54%
CAGR8.82%
Incremental Value$2.92bn

Technavio's chronic lymphocytic leukemia therapeutics market is segmented as below:

By Route Of Administration

By Therapy

By Geography

This study identifies the special drug designations for chronic lymphocytic leukemia therapeutics as one of the prime reasons driving the chronic lymphocytic leukemia therapeutics market growth during the next few years. Also, the rise in R&D activities related to innovative chronic lymphocytic leukemia therapeutics and increased use of predictive biomarkers for diagnosing chronic lymphocytic leukemia will lead to sizable demand in the market.

The report on the chronic lymphocytic leukemia therapeutics market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic lymphocytic leukemia therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca PLC, Biogen Inc., Bristol-Myers Squibb Company, F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Novartis AG, Pfizer Inc., R2T BIOPHARMA INC, Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the chronic lymphocytic leukemia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Route of Administration

7 Market Segmentation by Therapy

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â